Phase-change contrast agents (PCCAs) consisting of lipid-encapsulated low-boiling point perfluorocarbons can be used in conjunction with ultrasound for diagnostic and therapeutic applications. One benefit of PCCAs is site-specific activation, whereby the liquid core is acoustically vaporized into a bubble detectable via ultrasound imaging. For further evaluation of PCCAs in a variety of applications, it is useful to disperse these nanodroplets into an acoustically compatible stationary matrix. However, many traditional phantom preparations require heating, which causes premature thermal activation of low-boiling point PCCAs. Polyvinyl alcohol (PVA) cryogels do not require heat to set. Here we propose a simple method for the incorporation of the low-boiling point PCCAs utilizing octafluoropropane (OFP) and decafluorbutane (DFB) into PVA cryogels for a variety of acoustic characterization applications. We then demonstrate the utility of the phantoms by activating droplets with a focused transducer, visualizing the lesions with ultrasound imaging. At 1 MHz, consistent droplet activation was consistently observed at 2.0 MPa and 4.0 MPa for OFP and DFB respectively.
Full Text via ClinicalKey